GOLGA8J Activators
GOLGA8J Activators are chemical compounds that facilitate the enhancement of GOLGA8J's role in Golgi apparatus dynamics and vesicular trafficking. Forskolin, by increasing intracellular cAMP levels, indirectly augments GOLGA8J function by improving the assembly and maintenance of the Golgi apparatus, where GOLGA8J plays its part. Similarly, PIP2 serves asa precursor for secondary messenger generation, indirectly enhancing GOLGA8J's role in Golgi structure and vesicular trafficking by promoting the activity of phospholipase C and the production of IP3. GTPγS, by stabilizing G-proteins, and NEM, through modulation of vesicle fusion, both contribute to the maintenance of Golgi integrity, indirectly supporting GOLGA8J's function. NADPH, essential for lipid synthesis, aids in maintaining the structural integrity of the Golgi membrane, thereby indirectly supporting GOLGA8J's role in the Golgi apparatus. Brefeldin A and Monensin, through their respective actions on protein transport and cation exchange, disrupt and then encourage the reassembly of the Golgi apparatus, which indirectly requires GOLGA8J activity for proper function. Ionomycin boosts GOLGA8J's function by increasing intracellular calcium levels, which activate calcium-dependent enzymes crucial for Golgi structure and function.
Additional activators include Okadaic Acid, which promotes hyperphosphorylation affecting Golgi dynamics; Nocodazole, which disrupts microtubule organization, thus influencing GOLGA8J's involvement in Golgi maintenance; and Cytochalasin D, which alters cytoskeletal arrangements leading to changes in Golgi dynamics that can indirectly enhance GOLGA8J function. Lastly, Golgicide A specifically inhibits GBF1, resulting in Golgi disruption and subsequent potential compensation mechanisms that may involve GOLGA8J. Collectively, these compounds, through their targeted effects on various cellular processes and pathways, indirectly enhance the functional activity of GOLGA8J by influencing the Golgi apparatus's architecture, dynamics, and the protein trafficking processes in which GOLGA8J is implicated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a labdane diterpenoid that activates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP levels can indirectly enhance GOLGA8J function by promoting Golgi apparatus assembly and maintenance, processes in which GOLGA8J is directly involved. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
NEM is a sulfhydryl-reactive compound that inhibits NSF (N-ethylmaleimide-sensitive factor) and can disrupt vesicle fusion. By affecting NSF activity, NEM can indirectly enhance GOLGA8J function by modulating the Golgi membrane dynamics and vesicle tethering. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is a fungal metabolite that inhibits protein transport from the ER to the Golgi apparatus. By disrupting the ARF1-GTPase cycle, it can indirectly enhance GOLGA8J function by causing Golgi apparatus disassembly and subsequent reassembly, potentially affecting the distribution and function of GOLGA8J within the Golgi. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can indirectly enhance GOLGA8J function by stimulating calcium-dependent enzymes that are involved in maintaining Golgi structure and function. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts Golgi function by altering cation exchange. This disruption can indirectly enhance GOLGA8J function by affecting Golgi apparatus homeostasis and prompting compensatory mechanisms that may involve GOLGA8J. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to hyperphosphorylation of proteins. Hyperphosphorylation can indirectly enhance GOLGA8J function by affecting Golgi dynamics and vesicular trafficking pathways in which GOLGA8J is involved. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole is a microtubule-depolymerizing agent that disrupts microtubule dynamics. Since microtubules are essential for Golgi apparatus positioning and function, nocodazole can indirectly enhance GOLGA8J function by affecting the organization and maintenance of the Golgi structure. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D is an inhibitor of actin polymerization, affecting cytoskeletal organization. By disrupting actin filaments, it can indirectly enhance GOLGA8J function by modulating the Golgi apparatus dynamics and potentially its role in vesicular trafficking. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Golgicide A specifically inhibits the activity of the Golgi-resident enzyme GBF1, a GEF for ARF1, leading to Golgi disruption. The inhibition of GBF1 can indirectly enhance GOLGA8J function by affecting Golgi apparatus architecture and potentially the role of GOLGA8J in Golgi dynamics. | ||||||